JP2008517988A5 - - Google Patents

Download PDF

Info

Publication number
JP2008517988A5
JP2008517988A5 JP2007538505A JP2007538505A JP2008517988A5 JP 2008517988 A5 JP2008517988 A5 JP 2008517988A5 JP 2007538505 A JP2007538505 A JP 2007538505A JP 2007538505 A JP2007538505 A JP 2007538505A JP 2008517988 A5 JP2008517988 A5 JP 2008517988A5
Authority
JP
Japan
Prior art keywords
formulation
drug
carrier particles
administration
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007538505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517988A (ja
JP5064226B2 (ja
Filing date
Publication date
Priority claimed from GBGB0423800.2A external-priority patent/GB0423800D0/en
Application filed filed Critical
Publication of JP2008517988A publication Critical patent/JP2008517988A/ja
Publication of JP2008517988A5 publication Critical patent/JP2008517988A5/ja
Application granted granted Critical
Publication of JP5064226B2 publication Critical patent/JP5064226B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007538505A 2004-10-27 2005-10-26 不眠症の治療において有用な新規な製剤処方 Expired - Lifetime JP5064226B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0423800.2 2004-10-27
GBGB0423800.2A GB0423800D0 (en) 2004-10-27 2004-10-27 New pharmaceutical formulations
PCT/GB2005/004147 WO2006046041A1 (en) 2004-10-27 2005-10-26 New pharmaceutical formulations useful in the treatment of insomnia

Publications (3)

Publication Number Publication Date
JP2008517988A JP2008517988A (ja) 2008-05-29
JP2008517988A5 true JP2008517988A5 (https=) 2008-12-11
JP5064226B2 JP5064226B2 (ja) 2012-10-31

Family

ID=33515600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538505A Expired - Lifetime JP5064226B2 (ja) 2004-10-27 2005-10-26 不眠症の治療において有用な新規な製剤処方

Country Status (13)

Country Link
US (4) US9265720B2 (https=)
EP (2) EP2340872B1 (https=)
JP (1) JP5064226B2 (https=)
CY (2) CY1118414T1 (https=)
DK (2) DK2340872T3 (https=)
ES (1) ES2610469T3 (https=)
GB (1) GB0423800D0 (https=)
HU (1) HUE030609T2 (https=)
LT (2) LT2340872T (https=)
PL (2) PL2340872T3 (https=)
PT (2) PT2340872T (https=)
SI (2) SI1807156T1 (https=)
WO (1) WO2006046041A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1715853A4 (en) 2004-02-17 2012-07-18 Transcept Pharmaceuticals Inc COMPOSITIONS FOR THE DISTRIBUTION OF HYPNOTICS IN THE FIELD OF MUNICHCHLEIMHÄUTE AND USE METHOD THEREOF
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070123562A1 (en) * 2005-05-25 2007-05-31 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the-night insomnia
US20080132535A1 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized Zolpidem Pharmaceutical Compositions
US20100055181A1 (en) * 2006-12-18 2010-03-04 Lupin Limited Controlled release dosage forms of zolpidem
CA2687085A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
BRPI0914164B1 (pt) * 2008-06-20 2019-04-30 Merck Patent Gmbh Comistura para produção de comprimidos de desintegração rápida em um processo de formação de comprimido direto, seus usos, e formulações de comprimido
EP2437730A4 (en) * 2009-05-20 2014-02-26 Lingual Consegna Pty Ltd ORAL AND / OR SUBLINGUAL THERAPEUTIC FORMULATION
CN105581991A (zh) * 2015-12-28 2016-05-18 安徽省逸欣铭医药科技有限公司 一种酒石酸唑吡坦舌下片及其制备方法
EA202190765A1 (ru) 2018-10-08 2021-07-01 Троикаа Фармасьютикалз Лимитед Растворы золпидема или его фармацевтически приемлемых солей для оромукозного введения
CN111939133A (zh) * 2019-05-16 2020-11-17 鲁南制药集团股份有限公司 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152744C (da) 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
SE8800080L (sv) 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8803935L (sv) 1988-10-31 1990-05-01 Kabivitrum Ab Laekemedelskomposition
JPH0665103A (ja) 1992-08-13 1994-03-08 ▲寛▼治 ▲高▼田 向精神薬のための速吸収性舌下投与製剤
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
SE9803239D0 (sv) 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
EP1005863A1 (en) 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
AU7937500A (en) * 1999-10-27 2001-05-08 Farmarc Nederland Bv Pharmaceutical composition containing midazolam
WO2001078725A2 (en) 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
CN1290525A (zh) 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US20040176359A1 (en) 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
AU2002259241B2 (en) 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of sedative-hypnotics through an inhalation route
EP1469848B1 (en) 2002-01-10 2008-03-19 Biovail Laboratories International Srl Sedative non-benzodiazepine formulations
CA2478101A1 (en) * 2002-03-06 2003-09-12 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablets
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20050208127A1 (en) 2002-06-10 2005-09-22 Kazuyoshi Ogasawara Rapidly disintegrating tablet and process for producing the same
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
CN1418631A (zh) 2002-12-19 2003-05-21 王登之 治疗失眠的佐匹克隆口腔崩解片及其制备方法
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
JP4739217B2 (ja) * 2003-05-07 2011-08-03 サムヤン コーポレイション 速く溶ける錠剤を製造するための高可塑性顆粒
US20050215521A1 (en) * 2003-12-22 2005-09-29 Karim Lalji Modafinil combination therapy for improving sleep quality
AU2005215782B2 (en) 2004-02-17 2011-04-21 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
EP1715853A4 (en) * 2004-02-17 2012-07-18 Transcept Pharmaceuticals Inc COMPOSITIONS FOR THE DISTRIBUTION OF HYPNOTICS IN THE FIELD OF MUNICHCHLEIMHÄUTE AND USE METHOD THEREOF
CN1290525C (zh) * 2004-07-13 2006-12-20 赵余庆 一种降血糖的植物提取物及其用途

Similar Documents

Publication Publication Date Title
KR100760536B1 (ko) 급성 장해 치료용 약제학적 조성물
JP2023166486A (ja) 経口投与型コルチコステロイド組成物
TWI583384B (zh) 包含4-胺基-5-氟-3-[6-(4-甲基哌嗪-1-基)-1h-苯并咪唑-2-基]-1h-喹啉-2-酮乳酸鹽單水合物之醫藥組合物
CA2704646C (en) Sustained-release tablets with hydromorphone
WO2007074856A1 (ja) 口腔内崩壊性固形製剤の製造法
WO2009034541A2 (en) Controlled release pharmaceutical dosage forms of trimetazidine
CN101505732A (zh) 低剂量阿片类镇痛剂舌下片及其制备方法
EA021784B1 (ru) Фармацевтические композиции с длительным высвобождением
NZ510275A (en) Controlled-release pharmaceutical formulations containing a CGMP PDE-5 inhibitor
RU2009141538A (ru) Твердые лекарственные формы, содержащие тадалафил
JPWO2008120548A1 (ja) 口腔内崩壊錠
JP2016166230A (ja) ナルブフィンを含有する製剤及びそれらの使用
JPH09500910A (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
JP2011148816A (ja) 口腔内速崩壊性錠
JP2008534562A (ja) 偏頭痛の治療に有用な新しい製薬組成物
JP2008517988A5 (https=)
WO2013082706A1 (en) Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufacturing
JPWO2007123021A1 (ja) 徐放性錠剤の製造方法
WO2014193528A1 (en) Amorphous dosage forms and methods
KR20190031444A (ko) 바깥 층 또는 부분에 존재하는 테스토스테론 화합물을 가진 약물 전달 시스템을 제조하기 위한 방법 및 이러한 약물 전달 시스템
EP4371558A1 (en) Sacubitril valsartan sodium sustained-release composition, and preparation method therefor and use thereof
CN1279908C (zh) 氨来呫诺双层口腔粘附片及其制备方法
JP2009235066A (ja) 被覆微粒子含有口腔内崩壊錠
CN110461310A (zh) 用于使用射频和有损耗的包衣粒子制备片剂的方法
WO2024220974A1 (en) Rimegepant fast-dissolving films for oral administration